Your browser doesn't support javascript.
loading
Triple drug therapy with GABA, sitagliptin, and omeprazole prevents type 1 diabetes onset and promotes its reversal in non-obese diabetic mice.
Lagunas-Rangel, Francisco Alejandro; Koshelev, Daniil; Nedorubov, Andrej; Kosheleva, Liudmila; Trukhan, Vladimir; Rabinovitch, Alexander; Schiöth, Helgi B; Levit, Shmuel.
Affiliation
  • Lagunas-Rangel FA; Department of Surgical Sciences, Functional Pharmacology and Neuroscience, Uppsala University, Uppsala, Sweden.
  • Koshelev D; Department of Surgical Sciences, Functional Pharmacology and Neuroscience, Uppsala University, Uppsala, Sweden.
  • Nedorubov A; Levicure LTD, Tel Aviv, Israel.
  • Kosheleva L; Department of Surgical Sciences, Functional Pharmacology and Neuroscience, Uppsala University, Uppsala, Sweden.
  • Trukhan V; Department of Surgical Sciences, Functional Pharmacology and Neuroscience, Uppsala University, Uppsala, Sweden.
  • Rabinovitch A; Levicure LTD, Tel Aviv, Israel.
  • Schiöth HB; Advanced Molecular Technology LLC, Moscow, Russia.
  • Levit S; Kelowna, BC, Canada.
Front Endocrinol (Lausanne) ; 13: 1028114, 2022.
Article in En | MEDLINE | ID: mdl-36339443

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Experimental / Diabetes Mellitus, Type 1 / Dipeptidyl-Peptidase IV Inhibitors Limits: Animals Language: En Journal: Front Endocrinol (Lausanne) Year: 2022 Document type: Article Affiliation country: Suecia Country of publication: Suiza

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Experimental / Diabetes Mellitus, Type 1 / Dipeptidyl-Peptidase IV Inhibitors Limits: Animals Language: En Journal: Front Endocrinol (Lausanne) Year: 2022 Document type: Article Affiliation country: Suecia Country of publication: Suiza